Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | KCNJ6 | P48051 | 11/20 | 0.40 |
| ▸ | KCNJ3 | P48549 | 11/20 | 0.40 |
| ▸ | KCNJ5 | P48544 | 8/20 | 0.40 |
| ▸ | ESR1 | P03372 | 3/20 | 0.40 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.35 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.35 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.35 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | HTR2B | P41595 | 1/20 | 0.35 |
| ▸ | MAT2A | P31153 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1132025 | 0.87 | PTPN1 (0.43) | CNR1HPGDKCNJ6KCNJ3KCNJ5 | |
| SCHEMBL3887462 | 0.83 | ALOX5 (0.45) | CNR1HPGDKCNJ6KCNJ3KCNJ5 | |
| SCHEMBL3887467 | 0.83 | ALOX5 (0.45) | CNR1HPGDKCNJ6KCNJ3KCNJ5 | |
| SCHEMBL1131500 | 0.81 | CNR1 (0.43) | CNR1HPGDKCNJ6KCNJ3KCNJ5 | |
| SCHEMBL1131498 | 0.81 | CNR1 (0.43) | CNR1HPGDKCNJ6KCNJ3KCNJ5 | |
| SCHEMBL1131499 | 0.79 | CNR1 (0.48) | CNR1HPGDKCNJ6KCNJ3KCNJ5 | |
| SCHEMBL1131611 | 0.74 | PTGS2 (0.43) | KCNJ6KCNJ3KCNJ5ESR1 | |
| SCHEMBL5861842 | 0.74 | PTGS2 (0.43) | KCNJ6KCNJ3KCNJ5ESR1 | |
| SCHEMBL5215880 | 0.74 | ESR1 (0.52) | CNR1HPGDESR1HTR2AHTR2C | |
| SCHEMBL1131971 | 0.71 | CMKLR1 (0.41) | CNR1HPGDKCNJ6KCNJ3KCNJ5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1663105-B1 | CYCLOALKYL HETEROCYCLES FOR TREATING HEPATITIS C VIRUS | BRISTOL MYERS SQUIBB CO (US) | 2011-02-16 | — | — | EP | disclosed |